D
uniQure N.V. QURE
$25.32 -$1.25-4.71% NASDAQ
Recommendation
Prev Close
$26.57
Volume
1
Avg Vol (90D)
3,473,357
Market Cap
$1.66B
Dividend & Yield
--
52-Week Range
$6.11 - $71.50
P/E (TTM)
--
EPS (TTM)
-$4.39
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Breakout Momentum Plays You Need to Know About
10/23/2025 - MarketBeat
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
12/2/2025 - Globe Newswire
uniQure N.V. (NASDAQ:QURE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
11/30/2025 - MarketBeat
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
11/28/2025 - PR Newswire
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty
11/25/2025 - Insider Monkey
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
11/24/2025 - Globe Newswire
SG Americas Securities LLC Makes New $1.32 Million Investment in uniQure N.V. $QURE
11/23/2025 - MarketBeat
uniQure (NASDAQ:QURE) Stock Rating Lowered by Wall Street Zen
11/23/2025 - MarketBeat
QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
11/22/2025 - PR Newswire
uniQure (NASDAQ:QURE) Trading Down 8.7% - Here's Why
11/20/2025 - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
11/20/2025 - PR Newswire
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3
11/19/2025 - Insider Monkey
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $215,000 Investment in uniQure N.V. $QURE
11/17/2025 - MarketBeat
FY2025 EPS Estimate for uniQure Increased by Analyst
11/15/2025 - MarketBeat
FY2025 Earnings Estimate for uniQure Issued By HC Wainwright
11/15/2025 - MarketBeat
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
11/14/2025 - Globe Newswire
FY2029 EPS Estimates for uniQure Decreased by HC Wainwright
11/14/2025 - MarketBeat
10,808 Shares in uniQure N.V. $QURE Purchased by Teacher Retirement System of Texas
11/14/2025 - MarketBeat
uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
11/14/2025 - PR Newswire
uniQure (NASDAQ:QURE) Shares Down 7.4% After Analyst Downgrade
11/13/2025 - MarketBeat
uniQure (NASDAQ:QURE) Price Target Lowered to $60.00 at Wells Fargo & Company
11/13/2025 - MarketBeat
Q4 Earnings Forecast for uniQure Issued By Leerink Partnrs
11/13/2025 - MarketBeat
FY2025 Earnings Estimate for uniQure Issued By William Blair
11/13/2025 - MarketBeat
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
11/12/2025 - Globe Newswire
QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop
10/3/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$15.75M
EBITDA (TTM)
-$160.37M
EBIT (TTM)
-$176.51M
Net Income (TTM)
-$235.15M
Balance Sheet
Total Assets (Q)
$888.38M
Total Debt (Q)
$531.66M
Total Liabilities (Q)
$659.64M
Book Value Per Share (Q)
$3.68
Cash Flow
Cash from Operations (TTM)
-$153.24M
Cash from Investing (TTM)
$93.13M
Cash from Financing (TTM)
$406.43M
Net Change in Cash (TTM)
$345.47M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.13
7-Day Total Return
-9.25%
30-Day Total Return
-60.39%
60-Day Total Return
45.27%
90-Day Total Return
67.57%
Year to Date Total Return
40.28%
1-Year Total Return
255.12%
2-Year Total Return
256.62%
3-Year Total Return
-2.73%
5-Year Total Return
-50.03%
52-week Low
Dec 04, 2024 - $6.11
52-week High
Oct 28, 2025 - $71.50
Valuation
Market Cap
$1.66B - Small Cap
Enterprise Value
$1.49B
Price/Sales (TTM)
98.74
Price/Book (Q)
7.22
Dividends and Shares
Shares Outstanding
58.52
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.uniqure.com
Phone Number
31 20 240 6000
Address
Paasheuvelweg 25
Amsterdam, 1105 BP
Country
Netherlands
Year Founded
1998
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed